This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo
メニュー

Zdravka Medarova, PhD
TransCode Therapeutics における Co-Founder and Chief Scientific Officer
スピーカー

アジェンダセッション

  • Phase 1 Clinical Testing of a First-in-Class ASO Therapeutic against Metastatic Cancer

    , 9:15am
    セッションを見る

このイベントで

前へ
次へ
Katsuhiko Miwa
CEO
ChromaJean

Zdravka を TIDES Asia: Oligonucleotide & Peptide Therapeutics で見る